GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celestial Biolabs Ltd (BOM:532871) » Definitions » Gross Profit

Celestial Biolabs (BOM:532871) Gross Profit : ₹0.25 Mil (TTM As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Celestial Biolabs Gross Profit?

Celestial Biolabs's gross profit for the three months ended in Dec. 2023 was ₹0.13 Mil. Celestial Biolabs's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.25 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Celestial Biolabs's gross profit for the three months ended in Dec. 2023 was ₹0.13 Mil. Celestial Biolabs's Revenue for the three months ended in Dec. 2023 was ₹0.37 Mil. Therefore, Celestial Biolabs's Gross Margin % for the quarter that ended in Dec. 2023 was 35.87%.

Celestial Biolabs had a gross margin of 35.87% for the quarter that ended in Dec. 2023 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Celestial Biolabs was 78.32%. The lowest was 28.27%. And the median was 39.53%.


Celestial Biolabs Gross Profit Historical Data

The historical data trend for Celestial Biolabs's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celestial Biolabs Gross Profit Chart

Celestial Biolabs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 202.73 19.59 - 0.58 0.63

Celestial Biolabs Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.17 0.12 0.12 0.13

Competitive Comparison of Celestial Biolabs's Gross Profit

For the Biotechnology subindustry, Celestial Biolabs's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celestial Biolabs's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celestial Biolabs's Gross Profit distribution charts can be found below:

* The bar in red indicates where Celestial Biolabs's Gross Profit falls into.



Celestial Biolabs Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Celestial Biolabs's Gross Profit for the fiscal year that ended in Mar. 2023 is calculated as

Gross Profit (A: Mar. 2023 )=Revenue - Cost of Goods Sold
=1.687 - 1.061
=0.63

Celestial Biolabs's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=0.368 - 0.236
=0.13

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.25 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Celestial Biolabs's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.13 / 0.368
=35.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Celestial Biolabs  (BOM:532871) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Celestial Biolabs had a gross margin of 35.87% for the quarter that ended in Dec. 2023 => Competition eroding margins


Celestial Biolabs Gross Profit Related Terms

Thank you for viewing the detailed overview of Celestial Biolabs's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Celestial Biolabs (BOM:532871) Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 59, Road No 12, TSIIC Tech Park, IDA Nacharam, Hyderabad, TG, IND, 500076
Celestial Biolabs Ltd is an India based biopharmaceutical company. It is engaged in the business activity producing and supplying of the biotechnological products. The company offers herbal, feed supplement and nutraceutical products. The proprietary herbal products of the group include BIOVITA, CADALMIN GAE, CEL-DIGEST, BIOLIV, RHUMACEL, CEL-CLEAR, Trem Plus, O-KOF, BIOPOWER GOLD, BIO-DNORM, DERMACEL, GYNOCEL, HEALTHONE, RELIFIN, and C-KAPS. The organization formulates and manufactures Ayurvedic proprietary products for the Indian market.

Celestial Biolabs (BOM:532871) Headlines

No Headlines